Ϫ1 ⅐ day Ϫ1 for 3 days (Iso3) or 7 days (Iso7)]-induced hypertrophied rat heart preparation under isovolumic contractionrelaxation. We evaluated pressure-time curves per beat, end-systolic pressure-volume and end-diastolic pressure-volume relations, and myocardial O 2 consumption per beat (V O2)-systolic pressure-volume area (PVA; a total mechanical energy per beat) linear relations at 240 beats/min, because Iso-induced hypertrophied hearts failed to completely relax at 300 beats/min. The LV relaxation rate at 240 beats/min in Iso-induced hypertrophied hearts was significantly slower than that in control hearts [saline 24 l/day for 3 and 7 days (Sa)] with unchanged contraction rate. The V O2-intercepts (composed of basal metabolism and Ca 2ϩ cycling energy consumption in excitationcontraction coupling) of V O2-PVA linear relations were unchanged associated with their unchanged slopes in Sa, Iso3, and Iso7 groups. The oxygen costs of LV contractility were also unchanged in all three groups. The amounts of expression of sarcoplasmic reticulum Ca 2ϩ -ATPase, phospholamban (PLB), phosphorylated-Ser 16 PLB, phospholemman, and Na ϩ -K ϩ -ATPase are significantly decreased in Iso3 and Iso7 groups, although the amount of expression of NCX1 is unchanged in all three groups. Furthermore, the marked collagen production (types I and III) was observed in Iso3 and Iso7 groups. These results suggested the possibility that lowering the heart rate was beneficial to improve mechanical work and energetics in isoproterenol-induced hypertrophied rat hearts, although LV relaxation rate was slower than in normal hearts. cardiac function; excitation-contraction coupling; systolic pressurevolume area; oxygen consumption CARDIAC HYPERTROPHY IS A MAJOR risk factor for the development of heart failure and sudden cardiac death. Therefore, to reduce mortality from cardiovascular diseases, elucidation of the mechanisms involved in cardiac hypertrophy is pivotal. It is recognized that activation of the sympathetic nervous system is associated with cardiac hypertrophy and heart failure in humans (4, 11). In addition, chronic treatment of hearts with an ␣,␤-stimulant, norepinephrine, or a ␤-stimulant, isoproterenol, induces cardiac hypertrophy accompanied with enhanced fibrosis among cardiac interstitial cells in experimental animal models (3, 21, 25, 26) . So far, various mechanisms for this remodeling have been proposed (25, 26, 10, 36) .
CARDIAC HYPERTROPHY IS A MAJOR risk factor for the development of heart failure and sudden cardiac death. Therefore, to reduce mortality from cardiovascular diseases, elucidation of the mechanisms involved in cardiac hypertrophy is pivotal. It is recognized that activation of the sympathetic nervous system is associated with cardiac hypertrophy and heart failure in humans (4, 11) . In addition, chronic treatment of hearts with an ␣,␤-stimulant, norepinephrine, or a ␤-stimulant, isoproterenol, induces cardiac hypertrophy accompanied with enhanced fibrosis among cardiac interstitial cells in experimental animal models (3, 21, 25, 26) . So far, various mechanisms for this remodeling have been proposed (25, 26, 10, 36) .
We have recently reported that 3-day and 7-day subcutaneous infusions of isoproterenol to rats induced cardiac hypertrophy with unchanged left ventricular (LV) systolic and diastolic functions compared with normal hearts that was reversible to the control levels after the cessation of infusion (8, 30) . In in vivo ejecting heart model, the significant decrease of mechanical work due to the decrease of LV volume (LVV) was observed. Furthermore, these short-term models did not show any marked differences in the LV mechanical work capability compared with that induced by a 2-wk isoproterenol infusion (30) . The expression levels of cardiac sarcoplasmic reticulum Ca 2ϩ -ATPase (SERCA2a), phospholamban (PLB), and phosphorylated Ser16 (phospho-ser 16 ) PLB (p-PLB) in these models were also decreased, suggesting the possibility that the Ca 2ϩ -handling of the cardiac myocyte was already altered (8, 30) . However, functional changes of molecules associated with the Ca 2ϩ -handling are not completely understood. Morphological analyses, functional studies using echocardiography and LV pressure-volume measurements, and molecular mechanism studies have been conducted in isoproterenolinduced rat cardiac hypertrophy model. However, the cardiac mechanoenergetic studies have not yet been well conducted. We have established a method to analyze specifically LV mechanical work and energetics in an excised, blood-perfused whole heart preparation with a cross-circulation method (29, (32) (33) (34) (35) . In the present study, we focused on the investigation of LV mechanical work and energetics in a isoproterenol-induced rat cardiac hypertrophy model. Some parts of these data have been reported previously in abstract form (16) . (3) . Osmotic minipump was removed from the neck 3 or 7 days after the implantation under pentobarbital anesthesia.
Surgical preparation. Experiments were performed on 36 excised, cross-circulated rat heart preparations from 11 Sa rats, 13 Iso3 rats, and 12 Iso7 rats as previously reported (5-7, 9, 16, 19, 31, 32, 34) . For each experiment, two retired breeder male crj:Wistar rats weighing 617 Ϯ 98 g were anesthetized with pentobarbital sodium (50 mg/kg ip) and used as blood supplier and metabolic supporter rats, respectively. All rats were intubated and heparinized (1,000 U iv). The bilateral common carotid arteries and right external jugular vein were cannulated with the arterial and venous cross-circulation tubing in metabolic supporter rats. The chest of the smallest rat as the heart donor was opened midsternally under artificial ventilation. The brachiocephalic artery and the right ventricle (RV) via the superior vena cava were cannulated and connected to the arterial and venous cross-circulation tubing from the support rat. The heartlung section was isolated from the left common carotid artery, descending aorta, inferior vena cava, and pulmonary trunk in this order. The beating heart was excised without interruption of coronary perfusion and supported by cross circulation with the metabolic supporter rat as previously reported in detail (6, 7) . The excised heart was maintained at 37°C.
A thin latex balloon (balloon membrane volume, 0.08 ml) fitted into the LV was connected to a pressure transducer (Life Kit DX-312; Nihon Kohden, Tokyo, Japan) and a 0.5-ml precision glass syringe with fine scales (minimum scale, 0.005 ml). LVV was changed and measured by adjusting the intraballoon water volume with the syringe in 0.02-to 0.05-ml steps between 0.08 and 0.20 ml. Systolic unstressed volume (V0) was determined by filling the balloon to the level where peak isovolumic pressure and hence systolic pressure-volume area (PVA; a total mechanical energy per beat; see Data analysis) were zero. The sum of intraballoon water volume and balloon material volume (0.08 ml) was used as an initial estimate of V 0. V0 was then finally determined as the volume-axis intercept of the best-fit endsystolic pressure (ESP)-volume relationship (ESPVR) in each vol-run. We obtained the best-fit ESPVR and end-diastolic pressure-volume relationship (EDPVR) from five to six different pressure (P)-volume (V) data with the two different exponential functions by means of the least-squares method (Delta-Graph; DeltaPoint, Monterey, CA) on a personal computer (6, 7, 32, 33) . Correlation coefficients of the best-fit ESPVRs and EDPVRs were higher than 0.91.
The LV epicardial electrocardiogram was recorded, and the heart rate was constantly maintained at 240 beats/min by electrical pacing of the right atrium. The pacing rate of 240 beats/min was adjusted to avoid causing incomplete relaxation or arrhythmia. The systemic arterial blood pressure of the supporter rat served as coronary perfusion pressure (90 -130 mmHg). Arterial pH, PO 2, and PCO2 of the supporter rat were maintained within their physiological ranges (pH ϭ 7.3-7.4; PO 2 ϭ 95-100 mmHg; PCO2 ϭ 35-40 mmHg) with supplemental oxygen and sodium bicarbonate. Thus the hypertrophied heart as well as the normal heart was circulated with blood under physiologically conditions.
Oxygen consumption. Myocardial oxygen (O 2) consumption was obtained as the product of coronary flow and coronary arteriovenous O 2 content difference (6). Myocardial O2 consumption per beat (V O2) was obtained as myocardial O2 consumption divided by heart rate (ϭpacing rate). This is the most important point. If pacing rate is decreased, myocardial O 2 consumption per minute will decrease. As shown previously (6, 7, 32, 33) , the V O2-PVA relation was linear in the rat LV. Its slope represents the oxygen cost of PVA, the efficiency of chemical to mechanical energy transduction (29) . Its V O2 intercept represents PVA-independent V O2. The PVA-independent V O2 is composed of V O2 for Ca 2ϩ handling in excitation-contraction coupling and basal metabolism (29) . Thus the V O2 at given PVA includes PVA-dependent V O2 for cross-bridge cycling and PVA-independent V O2 composed of V O2 for Ca 2ϩ handling in excitation-contraction coupling and basal metabolism (29) .
The RV was kept collapsed by continuous hydrostatic drainage of the coronary venous return, so that the RV PVA and hence PVAdependent V O2 were assumed to be negligible (6, 7, 32, 33) . The RV component of PVA-independent V O2 was calculated by multiplying biventricular PVA-independent V O2 in each contractile state with the ratio of RV weight divided by the sum of RV and LV weights. The RV PVA-independent V O2 (6, 7, 32, 33) was subtracted from the total V O2 to yield LV V O2. The LV, including the septum, and the RV were weighed for normalizing LVV.
Experimental protocol. LV pressure, V O2, and PVA data during isovolumic contractions were obtained at five to six different volumes (mean volume range, 0.12 Ϯ 0.02 ml/g; vol-run) in each Sa (n ϭ 11), Iso3 (n ϭ 13), and Iso7 heart (n ϭ 12). The control vol-run was performed without any inotropic interventions. After the control vol-run, Ca 2ϩ -induced positive inotropic run (Ca 2ϩ ino-run) at midrange LVV [mLVV; 0.13 ml ϭ water volume infused into the balloon (ϭ0.05 ml) plus V 0 (ϭ0.08 ml)] was performed in Sa hearts (n ϭ 4), Iso3 hearts (n ϭ 8), and Iso7 hearts (n ϭ 7). The mean values for mLVV (normalized for 1 g) were 0.18 Ϯ 0.01 ml/g in Sa rats (n ϭ 11), 0.15 Ϯ 0.01 ml/g in Iso3 rats (n ϭ 13), and 0.15 Ϯ 0.01 ml/g in Iso7 rats (n ϭ 12; Table 3 ). These values were significantly smaller in Iso3 and Iso7 groups than that of Sa group because of the concentric hypertrophy (Fig. 1A) . The infusion rate of 1% CaCl 2 solution was increased in steps up to 4 -6 ml/h at 5-8 min interval.
To measure basal metabolism, the cardiac arrest was induced by infusing KCl (0.5 M) into the coronary perfusion tubing at a constant rate in Sa, Iso3, and Iso7 groups (n ϭ 7 each), which was adjusted to abolish electrical excitation under monitoring ventricular electrocardiograms but not to generate any KCl-induced constriction of coronary vessels (7, 32) . In each steady state, data were sampled at 500 Hz for 2 s simultaneously, and the sampling was usually repeated three times at intervals of 0.5-1 min to minimize the noise derived from the measurement system. Mean values of three repeated values were used for analysis.
Lactate measurements. Blood lactate was measured with Lactate Pro (Arkray, Kyoto, Japan). The mean values of arteriovenous lactate difference at the maximum LVV loading (ϭthe maximum O 2 demand) during control vol-runs were 0.3 Ϯ 0.4 mM in Sa group, 0.2 Ϯ 0.5 mM in Iso3 group, and 0.3 Ϯ 0.2 mM in Iso7 group. In each group, lactate production was negligible at the steady state of the maximum LVV loading.
Data analysis. We attempted to fit the exponential equations (see Eq. 1 in Table 3 ) to an experimentally obtained series of five to six paired LV P-V data to obtain a set of ESPVR and EDPVR. Thus we determined PVA by subtracting the area under the best-fit EDPVR from the area under the best-fit ESPVR (1, 19, 31) . In the present study, we calculated PVA at mLVV (PVA mLVV) to assess LV mechanical work based on our studies (1, 6, 19, 32, 33) .
O 2 cost of LV contractility. We obtained the specific best-fit curves for the observed ESP mLVV and ESP (0 mmHg at V0) with ESPVR function in the control vol-run by the least-squares method, and we calculated PVA mLVV during Ca 2ϩ infusion on a personal computer (20, 27, 32, 33) . The parallelism of the V O2-PVA linear relation during Ca 2ϩ infusion has been confirmed in normal rat heart (27) and also was confirmed in the present Iso3 and Iso7 hearts (n ϭ 3 each). From the parallelism, the lines including all V O2-PVA data obtained during Ca 2ϩ infusion in steps at mLVV were drawn in parallel to the control V O2-PVA relation line, as described previously (6, 20, 27, 33) . The gradually increased V O2 intercept values (PVA-independent V O2 values) of the lines proportional to the enhanced LV contractility induced by Ca 2ϩ were obtained by this procedure. Our proposed index for LV contractility, eEmax, was calculated from a triangular area equivalent to PVAmLVV (27, 33) . The O2 cost of LV contractility was the slope of the relationship between PVAindependent V O2 and eEmax (27, 33) .
Analyses of one-beat LV pressure-time curve by hybrid logistic function and logistic function. To evaluate the LV systolic and diastolic functions, we analyzed the contraction rate [i corresponds to change in pressure over time (ϩdP/dtmax)] and relaxation rate (b corresponds to ϪdP/dtmax) from a best-fit function to one-beat LV pressure-time curve at mLVV during contraction and relaxation with our proposed hybrid logistic function (12) in Sa (n ϭ 11), Iso3 (n ϭ 13), and Iso7 (n ϭ 12) hearts. To evaluate LV end-diastolic relaxation rate or lusitropism, we analyzed logistic time constant (L) and the conventional exponential time constant (E) from respective best-fit functions to one-beat LV pressure-time curve at mLVV during relaxation with our proposed logistic function (13) and the monoexponential function in Sa (n ϭ 11), Iso3 (n ϭ 13), and Iso7 (n ϭ 12) group hearts.
Histological analysis. LV was fixed 3.7% paraformaldehyde in phosphate-buffered saline, embedded in paraffin, and cut into 6-m slices, which was stained with hematoxylin-eosin for morphological analysis or with Masson's trichrome (MTC) staining for detection of fibrosis. For morphometrical analysis, photographs of LV sections (n ϭ 3) cut at the same LV level from Sa, Iso3 and Iso7 (n ϭ 6 each heart) groups were taken at ϫ400 magnification, and cross-sectional images of cardiac myocytes (n ϭ 30 cells from each 6 heart) were digitized by digital microscope (Fujix digital camera HC-2500). LV collagen volume fraction was determined by counting computerized pixels in digital image of collagen area stained by MTC.
PCR. The mRNA expression levels of collagen types I␣1 and I␣2, II, III, and IV and GAPDH were analyzed by real-time PCR, as described previously (15) . Briefly, cDNA was initially denatured at 95°C for 30 s and then amplified by PCR for 40 cycles (95°C for 15 s, 60°C for 40 s). The primer sequences are summarized in the Table 1 . All data are expressed as the relative differences between Sa, Iso3, and Iso7 groups (n ϭ 6 each) after normalization to the GAPDH expression.
Polyacrylamide gel electrophoresis and Western blots for SERCA2a, PLB, phospho-Ser 16 
PLB, phospholemman, Na
and Na ϩ /Ca 2ϩ exchanger. Membrane proteins were isolated from the LV wall of each frozen heart. The frozen hearts were homogenized and centrifuged at 1,000 g for 10 min. The supernatants were centrifuged at 100,000 g for 60 min at 4°C. The 100,000 g pellets were cellular membrane fractions and used for immunoblotting of SERCA2a, PLB, phospho-Ser 16 PLB (p-PLB), phospholemman (PLM), Na ϩ /K ϩ -ATPase ␣-1 (NKA), and Na ϩ /Ca 2ϩ exchanger (NCX1). The same amounts of membrane proteins (10 g/lane) were separated on SDS-PAGE (10% for SERCA2 and NKA, 15% for PLB, p-PLB and PLM, and 7.5% for NCX1) in a minigel apparatus (Mini-PROTEAN II; Bio-Rad) and transferred to polyvinyliodene difluoride membranes. The membranes were blocked (4% Block Ace; Dainippon Pharmaceutical) and then incubated with anti-SERCA2a antibody (1:1,000 dilution; Affinity Bio Reagents), anti-PLB antibody Fig. 3 . A: normalized LV pressure-time curves at midrange LV volume (0.05 ml of balloon water volume) in Sa (E; n ϭ 11), Iso3 (OE; n ϭ 13), and Iso7 (F) hearts (n ϭ 12). From end-diastolic pressure-time curves surrounded by the frame, we obtained logistic and exponential time constants. B: mean logistic time constants. C: mean exponential time constants. *P Ͻ 0.05 vs. Sa hearts.
(1:2,000 dilution; Upstate Biotechnology), anti-p-PLB (Ser 16 ) antibody (1:1,000 dilution; Upstate Biotechnology), anti-PLM antibody (1:100 dilution; Abgent), or anti-NKA antibody (1:10,000 dilution; Upstate Biotechnology) and anti-NCX1 antibody (1:200 dilution; a generous gift from Dr. Iwamoto, Fukuoka University). The antigens were detected by the luminescence method (ECL Western blotting detection kit; Amersham) with peroxidase-linked anti-mouse IgG (1:2,000 dilution) or peroxidase-linked anti-rabbit IgG (1:2,000 or 1:5,000 dilution). After immunoblotting, the film was scanned with a scanner, and the intensity of the bands was calculated by NIH image analysis.
Systemic blood pressure and heart rate measurement in conscious rats. Systolic blood pressure and heart rate were measured by tail-cuff method (Muromachi, Tokyo, Japan) as described previously (36) . Seven days after implantation of osmotic minipump, rat systolic blood pressure and heart rate of Sa (n ϭ 10) and Iso7 (n ϭ 5) groups were measured under conscious conditions longer than 2 h after removal osmotic minipump.
Statistical analysis. All data are expressed as means Ϯ SD. Multiple comparisons were performed by one-way or repeated-measured ANOVA with a posthoc Bonferroni/Dunn test. A value of P Ͻ 0.05 was considered statistically significant.
RESULTS

Cardiac weights.
We confirmed a formation of rat cardiac hypertrophy model by Iso3 or Iso7. LV and RV weight ratio to body weight in Iso3 and Iso7 groups were significantly higher than those of Sa group (Table 2) , although LV weight ratio to body weight in Iso7 group was significantly decreased due to increased body weight. These data are substantially the same as those previously reported by our laboratory (8, 30) . Our laboratory has already reported echocardiographic data of this hypertrophy model from 3 days to 16 wk (30) . According to these data, the wall thickness parameter, interventricular septum thickness during diastole (IVSTd) in Iso3 and Iso7 groups were significantly larger than that in Sa group, and these increases in IVSTd remained significant compared with their respective Sa group data for up to 16 wk (30) .
Histological and RT-PCR analysis. Microscopic examination depicts cardiomyocyte hypertrophy as evidenced by increased cell size and fibrosis in Iso3 and Iso7 groups (Fig. 1, A  and B) . Intraluminal LVVs in Iso3 and Iso7 groups were distinctly smaller than that in Sa group. The collagen area in Iso3 and Iso7 groups was significantly larger than Sa group (P Ͻ 0.05; n ϭ 6 each; Fig. 1C ). Size of LV cardiac cells was significantly larger in Iso3 (121 Ϯ 22% of Sa; n ϭ 30) and Iso7 groups (121 Ϯ 27% of Sa; n ϭ 30) than Sa group (P Ͻ 0.05).
The expression of each mRNA of collagen type 1␣ 1 and type 1␣ 2 and type 3 significantly increased in Iso3 group than Sa group (P Ͻ 0.05), although each mRNA of collagen type 1␣ 2 and type 3 significantly decreased in Iso7 group (Fig. 1D) .
LV pressure-time curves. Pacing at 300 beats/min induced LV incomplete relaxations, whereas pacing at 240 beats/min induced LV complete relaxations in Iso3 and Iso7 groups (Fig. 2) . Figure 3A shows normalized LV pressure-time curves at mLVV (0.05 ml) in each Sa, Iso3, and Iso7 rat hearts at 240 beat/min. The mean contraction rate (ϩdP/dt max ) was not significantly different among three groups (Sa, 3.8 Ϯ 1.0 mmHg/ms; Iso3, 4.1 Ϯ 1.0 mmHg/ms; and Iso7, 3.5 Ϯ 0.8 mmHg/ms). The mean relaxation rate (ϪdP/dt max ) was also not significantly different in Iso3 (2.1 Ϯ 0.5 mmHg/ms) and Iso7 (1.9 Ϯ 0.4 mmHg/ms) group compared with that in Sa group (2.3 Ϯ 0.6 mmHg/ms). Mean L and E were significantly larger in Iso3 and Iso7 groups than those in Sa group, indicating that the end-diastolic relaxation rate in Iso3 and Iso7 groups became slower, although there were no significant differences in mean L and E between Iso3 and Iso7 groups (Fig. 3, B and C) . Figure 4 shows each representative ESPVR, EDPVR, and V O 2 -PVA relation. The shape of each ESPVR was similar in a Sa, Iso3, and Iso7 heart, and each slope and V O 2 intercept of the V O 2 -PVA relation was also similar in a Sa, Iso3, and Iso7 heart. Summarized data of LV mechanics are shown in Table 3 . Although best-fit parameters for ESPVR were significantly different in Iso3 and Iso7 groups from those in Sa group, mean ESP mLVV and PVA mLVV were unchanged in the three groups.
ESPVRs and V O 2 -PVA relations.
Mean slopes and V O 2 intercepts (PVA-independent V O 2 ) of V O 2 -PVA relationships did not show any differences among the three groups (Fig. 5, A and B) . The V O 2 intercept was composed of oxygen consumption for Ca 2ϩ handling in excitation-contraction coupling and for basal metabolism. There were no significant differences in the mean oxygen consumption for Ca 2ϩ handling in excitation-contraction coupling and for basal metabolism among the three groups (Fig. 5, C and D) .
Oxygen cost of LV contractility. Mean oxygen costs of LV contractility (the slope of PVA-independent V O 2 and eE max relation) for Ca 2ϩ in Sa (n ϭ 4), Iso3 (n ϭ 8), and Iso7 group hearts (n ϭ 7) are shown in Fig. 6 . The oxygen costs of LV contractility for Ca 2ϩ were unchanged in the three groups. Immunoblottings of SERCA2a, PLB, p-PLB, PLM, NKA, and NCX1. Expression of proteins representative for Ca 2ϩ handling in excitation-contraction coupling was studied with Western blot analysis in Fig. 7 . Summarized data of SERCA2a, PLB, p-PLB, PLM, NKA, and NCX1 expression in Iso3 (n ϭ 6) and Iso7 (n ϭ 7) compared with Sa (n ϭ 6) indicated that protein levels of SERCA2a, PLB, p-PLB, PLM, and NKA were significantly lower in Iso3 and Iso7 than Sa. The protein level of NCX1, however, was not significantly different among Sa, Iso3, and Iso7 (Fig. 7) .
Heart rate and systemic blood pressure. In conscious rats, heart rate was significantly decreased from 340 Ϯ 21 to 292 Ϯ 11 beats/min in Iso7 group, whereas systemic blood pressure was unchanged (Fig. 8 ).
DISCUSSION
Our laboratory has already published that the blood-perfused excised normal rat heart shows no dependency of LV mechanics and energetics on heart rates within 240 and 300 beats/min in Sa, Iso3, and Iso7 hearts. Right: mean protein levels of SERCA2, PLB, p-PLB, PLM, NKA, and NCX1. The mean protein levels of SERCA2, PLB, p-PLB, PLM, and NKA were significantly lower in Iso3 (n ϭ 6) and Iso7 (n ϭ 7) hearts than Sa hearts (n ϭ 6). *P Ͻ 0.05 vs. values in Sa (unpaired t-test). (20) . In the present hypertrophied rat hearts, LV systolic function was not impaired and the slope and V O 2 intercept of V O 2 -PVA relationship and the O 2 cost of LV contractility were unchanged by lowering the heart rate from 300 to 240 beats/ min, although the slower LV relaxation rate was found at 240 beats/min pacing. The lowering heart rate is beneficial to maintain the normal cardiac mechanical work and energetics in some type of diseased hearts such as the present hypertrophy.
V O 2 -PVA relation. In the isoproterenol-induced hypertrophied heats, the slope and V O 2 intercept of the V O 2 -PVA relation did not differ from those of control Sa hearts. The slope of the V O 2 -PVA relation (the oxygen cost of PVA) was unchanged, indicating that the ratio of chemomechanical energy transduction is unchanged (29) .
The V O 2 -intercept of V O 2 -PVA relation represents PVAindependent V O 2 . The PVA-independent V O 2 mainly consists of V O 2 for Ca 2ϩ handling in the excitation-contraction coupling and for basal metabolism (29) . Present results indicated no differences in myocardial O 2 consumption for Ca 2ϩ handling among all the three groups at 240 beats/min pacing (see Fig. 5C ). Since SERCA2a primarily consumed V O 2 for Ca 2ϩ handling (7, 28) , unchanged myocardial O 2 consumption for Ca 2ϩ handling in the hypertrophied heart suggests that SERCA2a can exert its function normally by lowering the heart rate.
There were no significant differences in basal metabolism among the three groups (Fig. 5D) -extrusion function of NCX1 is facilitated in the present hypertrophied hearts, the O 2 cost of LV contractility might have increased (14, 31) . A recent study reported that PLM regulates cardiac contractility by modulating NKA and/or NCX1, although at present the mechanism by which PLM regulates cardiac contractility is being actively investigated and is a topic of lively debated (23) . According to this report, the decreased amount of expression of PLM might have facilitated the function of NCX1. However, the unchanged O 2 cost of LV contractility indicates that there is no change in the relative function of SERCA2a and NCX1. Unchanged O 2 cost of LV contractility also suggests that SERCA2a can exert its function normally by lowering the heart rate (ϭ240 beats/min).
LV diastolic dysfunction. In the present hypertrophied heart, at a lower pacing rate (240 beats/min) than normal (300 beats/min), a significant slowing of LV relaxation rate was observed under unchanged systolic function. In the present study, the collagen production was markedly increased and the amount of expression of SERCA2a and phosphorylated-Ser 16 PLB was significantly decreased in Iso3 and Iso7 groups. However, SERCA2a can exert its function normally by lowering the heart rate. Therefore, the LV lusitropic dysfunction in the hypertrophied hearts is mainly related to increased collagen contents.
Present results indicated that lowering the heart rate enabled isoproterenol-induced hypertrophied rat hearts to exert normal mechanical work and energetics in blood-perfused whole heart preparations, although LV lusitropic dysfunction probably due to marked collagen production existed. Indeed, in all conscious rats survived in Iso7 group, we found that heart rate was significantly decreased to 292 beats/min under unchanged systemic blood pressure. Therefore, a decrease in heart rate may not reflect an increase in systemic blood pressure that would activate the baroreflex response, but reflect a decreased LV relaxation rate. In the present isolated heart preparation, controls by autonomic nerves and hormones were excluded, resulting in lower pacing rate (ϭ240 beats/min) to elicit LV complete relaxations. However, in in vivo hearts, sympathetic nerve activity might have contributed to facilitate LV relaxation rate, resulting in increased heart rate from 240 to around 290 beats/min.
We conclude that lowering the heart rate makes it possible to rescue the impairment of LV mechanical work and energetics in the present hypertrophied rat hearts, providing basic evidence for clinical therapy for patients with some type of cardiac failure.
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